Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEFIBROTIDE Cause Oxygen saturation decreased? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Oxygen saturation decreased have been filed in association with DEFIBROTIDE (DEFITELIO). This represents 0.2% of all adverse event reports for DEFIBROTIDE.

8
Reports of Oxygen saturation decreased with DEFIBROTIDE
0.2%
of all DEFIBROTIDE reports
2
Deaths
5
Hospitalizations

How Dangerous Is Oxygen saturation decreased From DEFIBROTIDE?

Of the 8 reports, 2 (25.0%) resulted in death, 5 (62.5%) required hospitalization, and 3 (37.5%) were considered life-threatening.

Is Oxygen saturation decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DEFIBROTIDE. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does DEFIBROTIDE Cause?

Off label use (1,323) Venoocclusive disease (576) Death (463) Multiple organ dysfunction syndrome (372) Venoocclusive liver disease (355) Intentional product use issue (201) Hypotension (169) Haemorrhage (156) Sepsis (143) Acute graft versus host disease (140)

What Other Drugs Cause Oxygen saturation decreased?

TREPROSTINIL (3,865) RITUXIMAB (3,139) AMBRISENTAN (1,791) MACITENTAN (1,666) TOCILIZUMAB (1,501) METHOTREXATE (971) PREDNISONE (880) PACLITAXEL (833) ADALIMUMAB (813) SELEXIPAG (810)

Which DEFIBROTIDE Alternatives Have Lower Oxygen saturation decreased Risk?

DEFIBROTIDE vs DEFLAZACORT DEFIBROTIDE vs DEGARELIX DEFIBROTIDE vs DELAFLOXACIN MEGLUMINE DEFIBROTIDE vs DELAMANID DEFIBROTIDE vs DELANDISTROGENE MOXEPARVOVEC-ROKL

Related Pages

DEFIBROTIDE Full Profile All Oxygen saturation decreased Reports All Drugs Causing Oxygen saturation decreased DEFIBROTIDE Demographics